ABCB1 and ovarian cancer: Expression of ABCB1 and ABCG2 correlates with resistance to cisplatin and paclitaxel in ovarian cancer cell lines (2008, KF28, TU-OM-1, OVCAR3, SKOV3) and in cells from patient and mouse ascites [89,90,91].